OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, will present its latest State of the Science Summit™ on diagnosis, management, and treatment of multiple myeloma. on Thursday, Nov. 15, from 5 to 9 p.m. at The Maxwell in New York City. The summit will be co-chaired by medical experts from the Tisch Cancer Institute at Mount Sinai: Ajai Chari, M.D., associate professor of medicine, director of clinical research of the Multiple Myeloma Program and associate director of clinical research, Mount Sinai Cancer Clinical Trails Office; and Sundar Jagannath, M.D., MBBS, director of the Multiple Myeloma Program and professor of medicine (hematology and medical oncology).
OncLive® to Host State of the Science 

The Center for Biosimilars®, an online resource for emerging therapies that focuses on improving patient outcomes, will present its latest Peer Exchange titled, “Biosimilars Stakeholders Summit: Best Practices for Biosimilars Education and Promotion” on Thursday, Dec. 13, at 12 p.m., 3 p.m., and 6 p.m. EST.

OncLive®, the leading digital provider of resources and information to oncology professionals, will host its latest State of the Science Summit™ on breast cancer. The event will take place on Wednesday Nov. 14 from 5 to 9 p.m. at the DoubleTree by Hilton Minneapolis Park Place in Minneapolis, Minnesota. The summit will feature the following co-chairs from the Mayo Clinic: Judy C. Boughey, M.D., chair, division of surgery research, and Matthew P. Goetz, M.D., co-principal investigator, Mayo Clinic Breast Cancer Specialized Program of Research Excellence.

OncLive®, the leading digital provider of resources and information to oncology professionals, will host its latest State of the Science Summit™ on non–small cell lung cancer (NSCLC) on Wednesday, Nov. 14 from 5 to 9 p.m. at the JW Marriott Orlando, Grande Lakes in Orlando, Florida. The summit will be chaired by Mark A. Socinski, M.D., executive medical director, Florida Hospital Cancer Institute.

Targeted Therapies in Oncology, an oncology publication that provides oncology professionals with cutting-edge research, data, and treatment strategies surrounding molecular and immune system targets, has appointed Robert L. Ferris, M.D., Ph.D., as its co-physician editor-in-chief.

OncLive®, the leading digital provider of resources and information to oncology professionals, surpassed 713,777-page views on Onclive.com for the month of October, announced Michael J. Hennessy Jr., president of MJH Associates, parent company of OncLive®.